BioHealth Capital Region – Regional Life Sciences Roundup – October 9, 2026
Each week, our Regional Roundup delivers the most important and timely life sciences news from around the region. From groundbreaking research to fundraising, new development projects, and who’s hiring — we bring you the top stories that matter most. Stay informed with a curated selection of the latest news, delivered directly to your inbox weekly.
The BioHealth Capital Region is seeing a new wave of investment, but the bigger story is what that investment is making possible. This week, Kaléo secured a $96.1 million BARDA contract to advance a treatment for chemical threat exposure, while SereNeuro Therapeutics closed an oversubscribed pre-seed round to develop non-opioid pain therapies. Meanwhile, Seraxis and Sernova finalized $11.2 million in financing to move their proposed merger and stem cell-derived diabetes therapy forward. Across the region, capital is flowing toward some of healthcare’s most complex challenges.
But funding is only part of the story. BullFrog AI is making progress in a drug discovery collaboration aimed at identifying overlooked targets for depression, while 60 Degrees Pharmaceuticals is preparing for a critical clinical readout and FDA discussions around its severe babesiosis program. These developments highlight the different paths companies are taking to turn promising science into treatments that could reach patients.
And the momentum extends beyond individual companies. BioHub Maryland’s new partnership with BioBuzz’s BioCatalyst program is expanding pathways into biomanufacturing careers, while Virginia’s nationally recognized workforce training efforts are supporting major life sciences investments. At the same time, the region’s companies are hiring across research, manufacturing, and clinical operations. From securing capital and advancing therapies to building the workforce needed to deliver them, this week’s developments show how the region is laying the groundwork for its next phase of growth.
Financial
Tracking the capital moving through the BioHealth Capital Region — funding rounds, M&A activity, and investment trends shaping Maryland, DC, and Virginia’s life sciences companies.
BetaNova Financing Grows to $11.2M
Seraxis and Sernova Biotherapeutics have closed an $11.2 million financing round to support their proposed merger into BetaNova Biotherapeutics. The funding will advance manufacturing and clinical development of SR-02, a stem cell-derived therapy for type 1 diabetes, with first-patient dosing in a Phase 1/2 trial targeted for early 2027. Read More >
SereNeuro Therapeutics Closes Oversubscribed Pre-Seed Financing
SereNeuro Therapeutics has closed an oversubscribed pre-seed financing round to advance its non-opioid pain treatment pipeline. The funding will support preclinical development of SN101, a stem cell-derived therapy for chronic joint pain, and SN102, a gene therapy targeting neuropathic pain. Read More >
Kaléo Awarded $96.1 Million BARDA Contract to Advance 2-PAM Auto-Injector for U.S. Chemical Threat Preparedness
Kaléo has been awarded a $96.1 million BARDA contract to advance its next-generation 2-PAM auto-injector for treating organophosphate and nerve agent poisoning. The funding will support late-stage development, FDA regulatory activities, manufacturing validation, and initial procurement, with additional contract options potentially adding $244.8 million. Read More >
TEDCO Announces Accepting the Federal and State Technology Partnership Program Grant
TEDCO has accepted a Federal and State Technology (FAST) Partnership Program grant from the U.S. Small Business Administration to expand its SBIR/STTR Proposal Lab. The program will help Maryland’s first-time and early-stage companies compete for federal funding, and it adds a new commercialization track for Phase I and II awardees. Read More >
People
Who we’re buzzing about this week — the leadership moves, board appointments, and rising names shaping the region’s life sciences community.
TEDCO President, Tammi Thomas, Selected as 2026 Influential Marylander
TEDCO President Tammi Thomas has been named one of The Daily Record’s 2026 Influential Marylanders, recognizing her leadership in strengthening Maryland’s innovation and entrepreneurial ecosystem. Thomas has helped expand TEDCO’s investor partnerships, access to capital, and programs supporting emerging technology and life sciences companies. Read More >
Anthony Mattacchione as Chief Financial Officer of Rose BioSolutions
Rose BioSolutions has appointed Anthony Mattacchione as Chief Financial Officer, bringing more than 20 years of financial leadership experience across biopharmaceuticals, life sciences, and technology. He will lead the company’s financial strategy as it strengthens its operations and supports clients navigating the complex path to commercialization, particularly in cell and gene therapy. Read More >
Why Arcellx’s Alumni Are the True Legacy of the $7.8B Gilead Exit
Gilead’s $7.8 billion acquisition of Arcellx represents more than a major biotech exit. As former Arcellx employees take on leadership roles, launch startups, and bring their expertise to other companies, their experience could help fuel the next generation of innovation across the BioHealth Capital Region. Read More >
Workforce
The hiring activity, team expansions, and talent trends driving growth across Maryland, DC, and Virginia’s life sciences and biotech employers.
Virginia Ranked No. 1 in Nation for Workforce Training Program by Area Development
Virginia has been ranked No. 1 nationally for workforce training by Area Development, recognizing the Virginia Talent Accelerator Program’s customized recruitment and training services. The program also supports life sciences manufacturing, including Merck’s $3 billion expansion in Elkton, which is expected to create 500 jobs. Read More >
FCWS Fall 2026 Job Fair
Frederick County Workforce Services will host its Fall 2026 Job Fair on October 29, connecting job seekers with regional employers. The event offers opportunities to explore careers across healthcare, biomedical research, and other industries. Read More >
8 BioHealth Capital Region Companies Named Among TIME’s World’s Top HealthTech Companies of 2026
The BioHealth Capital Region earned national recognition with eight local companies named to TIME and Statista’s World’s Top HealthTech Companies of 2026. The honorees span Maryland, Virginia, and Washington, D.C., highlighting the region’s growing impact across digital health, patient care, diagnostics, and healthcare technology. Read More>
Who’s hiring?!
Top Employer
As a global contract development and manufacturing organization (CDMO), Catalent helps pharmaceutical and biotechnology companies bring innovative treatments to patients worldwide. With expertise spanning biologics, gene therapies, and pharmaceutical manufacturing, Catalent plays a key role in advancing drug development and improving access to life-changing medicines.
Catalent offers opportunities for professionals looking to contribute to the future of biopharmaceutical innovation. Its teams support critical work across Manufacturing, Engineering, Quality, Validation, and Supply Chain operations, with opportunities to help bring new therapies from development to commercialization.
They are currently hiring across 30+ roles across BioHealth Capital Region. Apply Now >
Other employers and available roles we’re paying attention to this week:
- Precision for Medicine (Bethesda, MD) is hiring an Associate Scientist | Apply Now >
- Novo Nordisk (Petersburg, VA) is hiring a Chemical Manufacturing Technician II | Apply Now >
- Kite Pharma (Frederick, MD) is hiring a QA Documentation Specialist I | Apply Now >
- Bora Pharmaceuticals (Rockville, MD) is hiring a QC Analyst I – Environmental Monitoring | Apply Now >
- Elutia (Gaithersburg, MD) is hiring a Director of Marketing | Apply Now >
Clinical + Commercial
The latest clinical trial progress, regulatory milestones, and commercial launches from companies advancing science from the lab to the market across the BioHealth Capital Region.
Secretome Therapeutics Announces Initiation of THRIVE-2 Phase 2 Clinical Study Evaluating STM-01 in Duchenne Muscular Dystrophy
Secretome Therapeutics has launched its Phase 2 THRIVE-2 study evaluating STM-01, an investigational cell therapy for Duchenne muscular dystrophy. The trial will assess the treatment’s safety and potential to address inflammation and fibrosis associated with progressive skeletal and cardiac muscle damage. Read More >
60 Degrees Pharma Moves Babesiosis Program Toward January Readout and FDA Talks
60 Degrees Pharmaceuticals plans to report results from its severe babesiosis clinical trial in January 2027 and seek an FDA meeting to discuss a potential regulatory pathway for tafenoquine. The company is moving toward final analysis after enrolling 30 patients, marking a key step in its efforts to develop a treatment for the tick-borne disease. Read More >
Positive Progress in Drug Discovery Program
BullFrog AI may be uncovering depression drug targets that traditional discovery methods have overlooked. Its work with a top-five global pharmaceutical company has now reached key milestones, offering an early glimpse at what AI could reveal about one of the world’s most difficult-to-treat mental health conditions. Read More >
Ecosystem
The partnerships, programs, and policy moves building the BioHealth Capital Region’s life sciences infrastructure — and the organizations driving it forward.
Designing Biomanufacturing Facilities for Growth: 7 Lessons on Utilities, Talent and Long-Term Planning
Biomanufacturing facilities need more than advanced equipment to scale successfully. Industry experts from Pureflow and Samsung Biologics share seven key lessons on utility infrastructure, workforce planning, and long-term flexibility to support sustainable growth. Read More >
BioHub Maryland Joins BioBuzz’s BioCatalyst Workforce Program as Education + Ecosystem Partner
BioHub Maryland has joined BioBuzz’s BioCatalyst program as an Education + Ecosystem Partner, expanding access to hands-on biomanufacturing training and career development opportunities across Maryland. The partnership will connect students and job seekers with industry resources, mentorship, and pathways into the region’s growing life sciences workforce. Read More >
Other [Good] Reads
Editor’s picks from across the web — the stories, videos, and podcasts shaping the conversation in DMV biotech and life sciences this week.
CRB Horizons Report
CRB’s latest Horizons report looks across more than 400 R&D and manufacturing leaders to uncover where life sciences investment is accelerating, what companies are prioritizing, and how organizations are preparing for the industry’s next phase. Read More >
Act Now to Stop Drug Shortages
USP CEO Ronald Piervincenzi calls on pharmaceutical manufacturers to take a proactive approach to preventing drug shortages. He highlights how stronger supply chain transparency, reliability benchmarks, and more resilient sourcing strategies could help improve medicine availability and reduce disruptions. Read More >
On the Calendar
A few of the upcoming events, conferences, and networking opportunities across the BioHealth Capital Region’s life sciences ecosystem that you don’t want to miss.
Best Practices in Mammalian Cell Culture
Wednesday–Friday, October 14–16 • 9 AM–5 PM • Germantown, MD
Hosted by Bio-Trac | Register Now >
ARPA-H 2026 Emerging Health Innovators (EHI) Proposers’ Day
Tuesday, October 13 • 10AM-2PM • Virtual
Hosted by ARPA-H | Register Now >
IDWeek 2026
Wednesday–Saturday, October 21–24 • Washington, DC
Hosted by IDSA, SHEA, HIVMA, PIDS & SIDP | Register Now >
Did we miss something!? Drop us a line →
Stay connected to BioHealth Capital Region life sciences.
🔍 Explore companies → · 💼 Browse jobs → · 📅 See events → · 📰 Read more →
Get the BioHealth Capital Region Roundup every Friday.
The week’s most important life sciences news from BioHealth Capital Region— delivered to your inbox.
